Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic

Intravenous (IV) administration of antiviral monoclonal antibodies (mAbs) can be challenging, particularly during an ongoing epidemic, due to the considerable resources required for performing infusions. An ebolavirus therapeutic administered via intramuscular (IM) injection would reduce the burdens...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Erin, Cross, Robert W., McCavitt-Malvido, Maria, Abelson, Dafna M., Borisevich, Viktoriya, Stuart, Lauren, Agans, Krystle N., Mlakar, Neil, Marimuthu, Arumugapradeep, Deer, Daniel J., Shestowsky, William S., Kim, Do, Geisbert, Joan B., Zeitlin, Larry, Moyer, Crystal L., Roy, Chad J., Geisbert, Thomas W., Bornholdt, Zachary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228268/
https://www.ncbi.nlm.nih.gov/pubmed/35745509
http://dx.doi.org/10.3390/pathogens11060655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228268/
https://www.ncbi.nlm.nih.gov/pubmed/35745509
http://dx.doi.org/10.3390/pathogens11060655

Ejemplares similares